Abstract: Methods for treating and preventing pyrexia and other diseases in equines such as horses involving administering an oral pharmaceutical formulation containing metamizole are disclosed.
Abstract: Pharmaceutical formulations and methods useful for the treatment of anorexia and the stimulation of appetite and weight gain, and the management of weight loss in dogs and cats.
Type:
Grant
Filed:
February 26, 2016
Date of Patent:
March 31, 2020
Assignee:
Kindred Biosciences, Inc.
Inventors:
William Buhles, Richard Cortez, Kristin Maas, Geeta Srivastava, Daniel Perez
Abstract: Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.
Abstract: Provided are various embodiments relating to IL13R/IL4R contiguous polypeptides derived from companion animal species and that bind to IL13 and/or IL4. Such contiguous polypeptides can be used in methods to treat IL13 and/or IL4-induced conditions in companion animals, such as canines, felines, and equines.
Type:
Application
Filed:
April 20, 2018
Publication date:
February 13, 2020
Applicant:
Kindred Biosciences, Inc.
Inventors:
Hangjun Zhan, Lam Nguyen, Fawn Qian, Shyr Jiann Li
Abstract: Methods for treating pyrexia and other diseases in equines involving administering a parenteral formulation containing metamizole are disclosed.
Abstract: Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.
Abstract: Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.
Abstract: Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.
Abstract: Provided are various embodiments relating to anti-IL31 antibodies binding to canine IL31. Such antibodies can be used in methods to treat IL31-induced conditions in companion animals, such as canines, felines, and equines.
Abstract: Methods for treating and preventing pyrexia and other diseases in equines such as horses involving administering an oral pharmaceutical formulation containing metamizole are disclosed.
Abstract: Pharmaceutical formulations and methods useful for the treatment of anorexia and the stimulation of appetite and weight gain, and the management of weight loss in dogs and cats.
Type:
Application
Filed:
February 26, 2016
Publication date:
January 25, 2018
Applicant:
Kindred Biosciences, Inc.
Inventors:
William Buhles, Richard Cortez, Kristin Maas, Geeta Srivastava, Daniel Perez
Abstract: Methods for delivering a drug to an animal while preventing or reducing the risk of exposure of a human to the drug are provided in which the involved prescribers, pharmacies, veterinarians, and/or owners are registered in one or more computer databases. Embodiments are also provided in which registered owners or other registrants receive counseling information concerning the risks attendant to human exposure to the drug. Embodiments are also provided in which a global positioning system, mobile device, Internet, radio frequency identification chips, and/or other electronic devices and systems are utilized.